I am the Chief of Division of Hematology/Oncology at Henry Ford Cancer Institute/Henry Ford Health System. I am a medical oncologist by training and my area of interest is lung cancer research in general and drug development in lung cancer, in particular. I have conducted and participated in many lung cancer specific trials and in phase I trials, including investigator initiated trials based on laboratory research. I have also been a principal investigator of a Southwest Oncology Group trial, S0528, S1507 and NCI protocol 7389. I was a co-author on major phase III trials ALEX and Keynote 189 which changed the standard of care. I have also engaged in many epidemiologic studies in the field of lung cancer, publishing on features of lung cancer in African Americans and in young patients. I have served as one of the PIs of multi-PI R21 to identify ‘driver’ genetic alterations in African-American lung cancer patients. I served as the co-leader of the Molecular Therapeutics Program of the Core Cancer Center Grant of Karmanos Cancer Institute before joining University of Michigan. I was also the site PI for the NO1 grant awarded to the California Cancer Consortium. Subsequently, I was co-leader of the Thoracic Oncology Research Program and the Mary Lou Kennedy Research Professor in Thoracic Oncology at the University of Michigan, where I worked before joining Henry Ford Cancer Institute. My clinical research experience spans 20 years. I am also a member of the steering Committee of the Lung Cancer Committee of Southwest Oncology Group (SWOG). I am a member of the Editorial Board of Clinical Lung Cancer and a reviewer for many journals including New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology and Journal of Thoracic Oncology. I have also served as faculty for the annual meeting of the American Society of Clinical Oncology (ASCO) and as a member of the Education Committee of ASCO. I am a member of the Communications Committee of the International Association of Study of Lung Cancer (IASLC). I was awarded by the NCI the Cancer Clinical Investigator Team Leadership Award in 2012.